Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Moderna vaccine trial pleases investors, EBITDAC backlash, Huawei sanctions

Moderna vaccine trial pleases investors, EBITDAC backlash, Huawei sanctions

FromFT News Briefing


Moderna vaccine trial pleases investors, EBITDAC backlash, Huawei sanctions

FromFT News Briefing

ratings:
Length:
11 minutes
Released:
May 19, 2020
Format:
Podcast episode

Description

Positive results from the first US Covid-19 trial raised investors’ hopes of an economic rebound, Chinese self-driving car start-ups have been accelerating pilot projects as US rivals sit idle, and bond investors have hit out at the growing trend of companies reporting “earnings before coronavirus”. Plus, the FT’s Kiran Stacey explains what the latest US sanctions against Huawei mean for the Chinese telecoms company’s survival. To get free access to the FT’s Coronavirus Business Update newsletter for 30 days, visit ft.com/newsbriefingcovid or follow this link: https://www.ft.com/newsletter-signup/coronavirus?segmentId=9f398053-342f-c623-b5b3-1506d651696f. See acast.com/privacy for privacy and opt-out information.
Released:
May 19, 2020
Format:
Podcast episode

Titles in the series (100)

A rundown of the most important global business stories you need to know for the coming day, from the newsroom of the Financial Times. Available every weekday morning. See acast.com/privacy for privacy and opt-out information.